Atlas FDA

Edwards EVOQUE Tricuspid Valve Replacement System

FDA premarket approval P230013/S013 · decided 2025-10-31

Approval details

PMA number
P230013
Supplement
S013
Supplement type
Normal 180 Day Track
Supplement reason
Labeling Change - Indications/instructions/shelf life/tradename
Trade name
Edwards EVOQUE Tricuspid Valve Replacement System
Generic name
Percutaneously Delivered Prostheses and Tricuspid Valves
Applicant
Edwards Lifesciences, LLC
Date received
2025-05-06
Decision date
2025-10-31
Days to decision
178 days
Decision code
APPR
Product code
NPW
Advisory committee
Cardiovascular
Expedited review
No
Location
Irvine, CA
Statement
Approval for a revision to the Instructions for Use to add the results of the Full Cohort of the TRISCEND II trial.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.

510(k) clearances by this applicant

RecordFirmDate
Respiration Rate algorithm (K251326)Edwards Lifesciences, LLC2026-06-11
HemoSphere Nano Monitor (HSNANO1) (K253186)Edwards Lifesciences, LLC2026-02-24
Edwards MC3 Tricuspid annuloplasty ring (4900) (K251982)Edwards Lifesciences, LLC2025-09-23
Carpentier-Edwards Physio Annuloplasty Ring (4450) (K251688)Edwards Lifesciences, LLC2025-09-17
Hypertension Prediction Index (HePI) Algorithm (K242518)Edwards Lifesciences, LLC2025-05-15
FloTrac sensors; FloTrac Jr sensors; Acumen IQ sensors; VolumeView sensors (K242909)Edwards Lifesciences, LLC2025-03-21
Fogarty Thru-Lumen Embolectomy Catheter (K240078)Edwards Lifesciences, LLC2024-08-28
Acumen Assisted Fluid Management (AFM) Software Feature (K233984)Edwards Lifesciences, LLC2024-08-02